175 related articles for article (PubMed ID: 34532125)
1. Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions.
Coffman AR; Sufficool DC; Kang JI; Hsueh CT; Swenson S; McGee PQ; Nagaraj G; Patyal B; Reeves ME; Slater JD; Yang GY
J Gastrointest Oncol; 2021 Aug; 12(4):1753-1760. PubMed ID: 34532125
[TBL] [Abstract][Full Text] [Related]
2. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
3. Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.
Hong TS; Wo JY; Borger DR; Yeap BY; McDonnell EI; Willers H; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Tanguturi S; Goyal L; Murphy JE; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Tanabe KK; Ferrone CR; Ryan DP; Iafrate AJ; DeLaney TF; Zhu AX
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954285
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of Proton stereotactic body radiation therapy for liver metastases.
Kang JI; Sufficool DC; Hsueh CT; Wroe AJ; Patyal B; Reeves ME; Slater JD; Yang GY
J Gastrointest Oncol; 2019 Feb; 10(1):112-117. PubMed ID: 30788166
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience.
Hijazi H; Campeau MP; Roberge D; Donath D; Lapointe R; Vandenbroucke-Menu F; Taussky D; Boudam K; Chan G; Bujold A; Delouya G
Cureus; 2016 Dec; 8(12):e935. PubMed ID: 28123916
[TBL] [Abstract][Full Text] [Related]
6. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.
Anstadt EJ; Shumway R; Colasanto J; Grew D
J Gastrointest Oncol; 2019 Apr; 10(2):330-338. PubMed ID: 31032102
[TBL] [Abstract][Full Text] [Related]
7. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
8. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer.
Aghdam N; Repka MC; McGunigal M; Pepin A; Paydar I; Rudra S; Paudel N; Pernia Marin M; Suy S; Collins SP; Barnes W; Collins BT
Front Oncol; 2020; 10():572564. PubMed ID: 33425723
[TBL] [Abstract][Full Text] [Related]
11. A single-institutional experience with low dose stereotactic body radiation therapy for liver metastases.
Kowalchuk RO; Waters MR; Richardson KM; Spencer KM; Larner JM; Kersh CR
Rep Pract Oncol Radiother; 2020; 25(6):987-993. PubMed ID: 33100916
[TBL] [Abstract][Full Text] [Related]
12. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases.
Scouarnec C; Pasquier D; Luu J; le Tinier F; Lebellec L; Rault E; Lartigau E; Mirabel X
Front Oncol; 2019; 9():732. PubMed ID: 31448234
[No Abstract] [Full Text] [Related]
14. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.
Weykamp F; Hoegen P; Klüter S; Spindeldreier CK; König L; Seidensaal K; Regnery S; Liermann J; Rippke C; Koerber SA; Buchele C; Debus J; Hörner-Rieber J
Front Oncol; 2021; 11():610637. PubMed ID: 34178616
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer.
Li S; Dong D; Geng J; Zhu X; Shi C; Zhang Y; Wang H; Zhou S; Wu H; Cai Y; Li Y; Wang W
Front Oncol; 2019; 9():1080. PubMed ID: 31681609
[No Abstract] [Full Text] [Related]
17. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
18. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
[TBL] [Abstract][Full Text] [Related]
19. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
[No Abstract] [Full Text] [Related]
20. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
